DYBIX
Price
$10.71
Change
-$0.02 (-0.19%)
Updated
Jun 10 closing price
Net Assets
176.73M
PTYIX
Price
$11.21
Change
-$0.02 (-0.18%)
Updated
Jun 10 closing price
Net Assets
3.63B
Interact to see
Advertisement

DYBIX vs PTYIX

Header iconDYBIX vs PTYIX Comparison
Open Charts DYBIX vs PTYIXBanner chart's image
DYBIX vs PTYIX Comparison Chart in %
View a ticker or compare two or three
VS
DYBIX vs. PTYIX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYBIX is a Hold and PTYIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PTYIX has more cash in the bank: 3.64B vs. DYBIX (177M). PTYIX (4.20) and DYBIX (4.12) have matching dividends . DYBIX was incepted earlier than PTYIX: DYBIX (18 years) vs PTYIX (10 years). DYBIX (0.85) is less costly to investors than PTYIX (0.50). DYBIX is a more actively managed with annual turnover of: 16.77 vs. PTYIX (14.20). DYBIX has a lower initial minimum investment than PTYIX: DYBIX (1000) vs PTYIX (500000). PTYIX (9.45) and DYBIX (9.07) have marching annual gain over last year. PTYIX return over 5 years is better than : 7.23 vs. DYBIX (-1.61).
DYBIXPTYIXDYBIX / PTYIX
Total Expense Ratio0.850.50170%
Annual Report Gross Expense Ratio0.850.50170%
Fund Existence18 years10 years-
Gain YTD3.0863.046101%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets177M3.64B5%
Annual Yield % from dividends4.124.2098%
Returns for 1 year9.079.4596%
Returns for 3 years14.3818.2779%
Returns for 5 years-1.617.23-22%
Returns for 10 years27.48N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYH2.970.10
+3.48%
Community Health Systems
SPMA25.090.01
+0.04%
Sound Point Meridian Capital Inc
SF70.46-0.94
-1.32%
Stifel Financial Corp
EOSE6.07-0.19
-3.04%
Eos Energy Enterprises
FLNA1.33-0.10
-6.69%
Filana Therapeutics Inc